Stocklytics Platform
Asset logo for symbol RLMD
Relmada Therapeutics
RLMD46
$3.48arrow_drop_up6.09%$0.20
Penny Stock
Asset logo for symbol RLMD
RLMD46

$3.48

arrow_drop_up6.09%

Trendlines, Support and Resistance

lock

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Technical Indicators

NameValueActioninfoPnL (10y)Last upd.
RSI40.99Neutral-49.8%
MACD-3.02Neutral22.0%
CCI-35.72Neutral-90.9%
ADX4.91Neutral-
ATR2.82Buy-
WILLR-73.42Neutral-86.1%
ROC-20.48Sell-59.0%
STOCHRSI59.68Neutral-67.7%

Indicator Ratings

Hold

Buy
1
12.50%
Hold
6
75.00%
Sell
1
12.50%
Ratings from: October
Total: 8
info

Balanced or Uncertain

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Relmada Therapeutics (RLMD) Technical Analysis

Relmada Therapeutics Inc (RLMD) is a pharmaceutical company that focuses on developing novel therapies for the treatment of central nervous system (CNS) disorders. In order to analyze the technical aspects of RLMD stock, various indicators are used. These indicators provide valuable insights into the stock's price trends, momentum, and volatility. One such indicator is the Relative Strength Index (RSI). RSI measures the speed and change of price movements and can be used to identify overbought or oversold conditions. Another important indicator is the Average Directional Index (ADX), which determines the strength of trends in the stock price. A high ADX value indicates a strong trend, while a low value suggests a weak trend. Moving Average Convergence Divergence (MACD) is a popular indicator used to identify potential trend reversals. It consists of two lines, the MACD line and the signal line. A crossover of these two lines can signal a buy or sell opportunity. Rate of Change (ROC) measures the percentage change in price over a specified period of time. It is used to assess the momentum of the stock. Stochastic Relative Strength Index (STOCHRSI) combines RSI and stochastic indicators to provide a more comprehensive analysis of the stock's momentum. Williams %R (WILLR) is another momentum indicator that measures overbought and oversold conditions. It ranges from 0 to -100, with readings below -80 indicating oversold conditions. Based on the analysis of these technical indicators, a rating can be assigned to RLMD stock. This rating helps investors make informed decisions about buying or selling the stock.
In conclusion, the technical analysis of Relmada Therapeutics Inc (RLMD) involves the use of various indicators to assess the stock's price trends, momentum, and volatility. These indicators, such as RSI, ADX, MACD, ROC, STOCHRSI, and WILLR, provide valuable insights into the stock's performance. By analyzing these indicators, investors can make informed decisions about buying or selling RLMD stock. It is important to note that technical analysis should be used in conjunction with other forms of analysis, such as fundamental analysis, to get a comprehensive understanding of the stock's potential. Investors should always consider their risk tolerance and investment goals before making any trading decisions.
add Relmada Therapeutics  to watchlist

Keep an eye on Relmada Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What are the technical signals for Relmada Therapeutics (RLMD) stock based on the last 30 days?

The technical analysis for Relmada Therapeutics (RLMD), using 8 key indicators (RSI, MACD, CCI, ADX, ATR, WILLR, ROC, STOCHRSI) over the last 30 days, reveals: 1 technical buy signals, including ATR. 1 technical sell signals, identified by ROC. 6 technical hold signals, associated with RSI, MACD, CCI, ADX, WILLR, and STOCHRSI. This analysis was last updated 2024 Oct 04.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media